AUM scale DW Healthcare Partners is a healthcare-focused private equity firm with over $2.7 billion in assets under management as of March 31, 2026, signaling substantial capital readiness for larger add-on acquisitions or platform investments in healthcare. Their growth-focused mandate suggests potential interest in mid-market healthcare software, device, and services acquisitions that can be scaled with additional PE capital.
Portfolio growth DWHP emphasizes value creation and accelerates growth for portfolio companies, indicating opportunities for revenue cycle optimization, marketing and digital transformation services, or strategic acquisitions that complement existing platform companies such as LKC Technologies, Vets Plus, and Willowood. Sales conversations can frame solutions as growth accelerators aligned with their partnership model.
Healthcare focus Specialization in healthcare investments and hands-on operating experience across owned entities positions DWHP as a buyer who values operational improvements and regulatory-aligned product development. Target opportunities in healthcare compliance software, clinical workflow optimization, medical device support services, and specialty pharma/biotech services that fit their lower-middle-market investment thesis.
Active investments Recent activity includes investments in LKC Technologies and Vets Plus, plus prior exits and acquisitions, signaling a continued appetite for platform-building deals in the healthcare space. This persistence suggests openness to new deal sourcing in diagnostics, medtech, and healthcare services with potential for add-ons to existing portfolio platforms.
Geographic and team footprint Based in Park City, Utah with a team of 51-200 employees, DWHP operates with a national investment reach and practical healthcare experience. This implies flexibility for regional market access advantages, potential co-investor opportunities, and a preference for partners who can demonstrate tangible strategic value to portfolio companies during growth phases.